Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin

Internal and Emergency Medicine

Volumn 12, Issue 2, 2017, Pages 147-155

  Garg, Pankaj ^a   Morris, Paul ^b,c   Fazlanie, Asma Lina ^b   Vijayan, Sethumadhavan ^b   Dancso, Balazs ^b   Dastidar, Amardeep Ghosh ^d   Plein, Sven ^a   Mueller, Christian ^e   Haaf, Philip ^a,e  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d BRISTOL ROYAL INFIRMARY   (United Kingdom)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Acute coronary syndrome; Cardiac biomarkers; High sensitivity cardiac troponin

Indexed keywords

BIOLOGICAL MARKER; TROPONIN;

ACUTE CORONARY SYNDROME; BIOASSAY; BLOOD; EARLY DIAGNOSIS; HUMAN; METABOLISM; PRIMARY PREVENTION; PROCEDURES;

ACUTE CORONARY SYNDROME; BIOLOGICAL ASSAY; BIOMARKERS; EARLY DIAGNOSIS; HUMANS; PRIMARY PREVENTION; TROPONIN;

EID: 85012207038     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-017-1612-1     Document Type: Review

References (50)

1. Thygesen K, Alpert JS, Jaffe AS et al (2012) Third universal definition of myocardial infarction. Eur Heart J 33:2551–2567. doi:10.1093/eurheartj/ehs184
2. Kavsak PA, MacRae AR, Lustig V et al (2006) The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. Am Heart J 152:118–125. doi:10.1016/j.ahj.2005.09.022
3. Gamble JHP, Carlton E, Orr W, Greaves K (2013) High-sensitivity troponin: six lessons and a reading. Br J Cardiol 20:109–112. doi:10.5837/bjc.2013.026
4. White HD (2011) Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol 57:2406–2408. doi:10.1016/j.jacc.2011.01.029
5. Agewall S, Giannitsis E, Jernberg T, Katus H (2011) Troponin elevation in coronary vs non-coronary disease. Eur Heart J. doi:10.1093/eurheartj/ehq456
6. LaDue JS, Wroblewski F, Karmen A (1954) Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction. Science 120:497–499
7. World Health Organization Expert Committee (1959) Hypertension and coronary heart disease: classification and criteria for epidemiological studies. First report of the expert committee on cardiovascular diseases and hypertension. WHO Tech Rep Ser 168
8. Panteghini M (1995) Enzyme and muscle diseases. Curr Opin Rheumatol 7:469–474
9. Danese E, Montagnana M (2016) An historical approach to the diagnostic biomarkers of acute coronary syndrome. Ann Transl Med 4:194. doi:10.21037/atm.2016.05.19
10. Gibler WB, Gibler CD, Weinshenker E et al (1987) Myoglobin as an early indicator of acute myocardial infarction. Ann Emerg Med 16:851–856. doi:10.1016/S0196-0644(87)80521-8
11. Thygesen K, Mair J, Giannitsis E et al (2012) How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 33:2252–2257. doi:10.1093/eurheartj/ehs154
12. Eggers KM, Oldgren J, Nordenskjöld A, Lindahl B (2004) Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 148:574–581. doi:10.1016/j.ahj.2004.04.030
13. Dolci A, Panteghini M (2006) The exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more. Clin Chim Acta 369:179–187. doi:10.1016/j.cca.2006.02.042
14. World Health Organization (1979) Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 59:607–609
15. Ebashi S, Kodama A (1965) A new protein factor promoting aggregation of tropomyosin. J Biochem 58:107–108
16. Katus HA, Remppis A, Looser S et al (1989) Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol 21:1349–1353. doi:10.1016/0022-2828(89)90680-9
17. Jaffe AS, Landt Y, Parvin CA et al (1996) Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for diagnosing acute myocardial infarction. Clin Chem 42:1770–1776
18. Balk EM, Ioannidis JP, Salem D et al (2001) Accuracy of biomarkers to diagnose acute cardiac ischemia in the emergency department: a meta-analysis. Ann Emerg Med 37:478–494. doi:10.1067/mem.2001.114905
19. Ooi DS, Isotalo PA, Veinot JP (2000) Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology. Clin Chem 46:338–344
20. Takeda S, Yamashita A, Maeda K, Maéda Y (2003) Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form. Nature 424:35–41. doi:10.1038/nature01780
21. Freda BJ, Tang WHW, Van Lente F et al (2002) Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol 40:2065–2071. doi:10.1016/S0735-1097(02)02608-6
22. Reichlin T, Hochholzer W, Bassetti S et al (2009) Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. doi:10.1056/NEJMoa0900428
23. Apple FS, Ler R, Murakami MM (2012) Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 58:1574–1581. doi:10.1373/clinchem.2012.192716
24. Mueller C (2014) Biomarkers and acute coronary syndromes: an update. Eur Heart J 35:552–556. doi:10.1093/eurheartj/eht530
25. Carlton EW, Cullen L, Than M et al (2015) A novel diagnostic protocol to identify patients suitable for discharge after a single high-sensitivity troponin. Heart 101:1041–1046. doi:10.1136/heartjnl-2014-307288
26. Weber M, Bazzino O, Navarro Estrada JL et al (2011) Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. Am Heart J 162:81–88. doi:10.1016/j.ahj.2011.04.007
27. Shah ASV, Anand A, Sandoval Y et al (2015) High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet 386:2481–2488. doi:10.1016/S0140-6736(15)00391-8
28. Zhelev Z, Hyde C, Youngman E et al (2015) Diagnostic accuracy of single baseline measurement of Elecsys Troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis. BMJ 350:h15. doi:10.1136/bmj.h15
29. Shah ASV, Newby DE, Mills NL (2013) High sensitivity cardiac troponin in patients with chest pain. BMJ 347:f4222
30. Røysland R, Kravdal G, Høiseth AD et al (2012) Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: the Akershus Cardiac Examination (ACE) 1 study. Clin Sci (Lond) 122:599–606. doi:10.1042/CS20110557
31. Sabatine MS, Morrow DA, de Lemos JA et al (2009) Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 30:162–169. doi:10.1093/eurheartj/ehn504
32. Carlson RJ, Navone A, McConnell JP et al (2002) Effect of myocardial ischemia on cardiac troponin I and T. Am J Cardiol 89:224–226. doi:10.1016/S0002-9149(01)02206-8
33. Jeremias A, Gibson CM (2005) Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 142:786–791. doi:10.7326/0003-4819-142-9-200505030-00015
34. Mueller M, Vafaie M, Biener M et al (2013) Cardiac troponin T: from diagnosis of myocardial infarction to cardiovascular risk prediction. Circ J 77:1653–1661. doi:10.1253/circj.CJ-13-0706
35. Twerenbold R, Wildi K, Jaeger C et al (2015) Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction. Circulation 131:2041–2050. doi:10.1161/CIRCULATIONAHA.114.014245
36. Newby LK, Jesse RL, Babb JD et al (2012) ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol 60:2427–2463. doi:10.1016/j.jacc.2012.08.969
37. Parikh RH, Seliger SL, deFilippi CR (2015) Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction. Clin Biochem 48:247–253. doi:10.1016/j.clinbiochem.2015.01.004
38. Dikow R, Hardt SE (2012) The uremic myocardium and ischemic tolerance: a world of difference. Circulation 125:1215–1216. doi:10.1161/CIRCULATIONAHA.112.093047
39. Haaf P, Reichlin T, Twerenbold R et al (2014) Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays. Eur Heart J 35:365–375. doi:10.1093/eurheartj/eht218
40. Roffi M, Patrono C, Collet J-P et al (2015) 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 37:ehv320. doi:10.1093/eurheartj/ehv320
41. Hamm CW, Bassand J-P, Agewall S et al (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevatio. Eur Heart J 32:2999–3054. doi:10.1093/eurheartj/ehr236
42. Logeart D, Beyne P, Cusson C et al (2001) Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain. Am Heart J 141:247–253. doi:10.1067/mhj.2001.111767
43. Reichlin T, Irfan A, Twerenbold R et al (2011) Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 124:136–145. doi:10.1161/CIRCULATIONAHA.111.023937
44. Haaf P, Drexler B, Reichlin T et al (2012) High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation 126:31–40. doi:10.1161/CIRCULATIONAHA.112.100867
45. Sandoval Y, Thordsen SE, Smith SW et al (2014) Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk. Eur Heart J Acute Cardiovasc Care 3:317–325. doi:10.1177/2048872614538411
46. Shah ASV, Griffiths M, Lee KK et al (2015) High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ 350:g7873. doi:10.1136/bmj.g7873
47. Rubini Giménez M, Twerenbold R, Boeddinghaus J et al (2016) Clinical effect of sex-specific cutoff values of high-sensitivity cardiac troponin T in suspected myocardial infarction. JAMA Cardiol 1:912. doi:10.1001/jamacardio.2016.2882
48. Neumann JT, Sörensen NA, Schwemer T et al (2016) Diagnosis of myocardial infarction using a high-sensitivity troponin I 1-hour algorithm. JAMA Cardiol 1:397. doi:10.1001/jamacardio.2016.0695
49. Rodriguez F, Mahaffey KW (2016) Management of patients with NSTE-ACS. J Am Coll Cardiol 68:313–321. doi:10.1016/j.jacc.2016.03.599
50. Carlton E, Greenslade J, Cullen L et al (2016) Evaluation of high-sensitivity cardiac troponin I levels in patients with suspected acute coronary syndrome. JAMA Cardiol 1:405. doi:10.1001/jamacardio.2016.1309